- Home
- TOPS vs NXL Comparison
TOPS vs NXL Comparison
Compare TOPS & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- NXL
- Stock Information
- Founded
- TOPS 2000
- NXL 2010
- Country
- TOPS Greece
- NXL United States
- Employees
- TOPS N/A
- NXL N/A
- Industry
- TOPS Marine Transportation
- NXL Medical Specialities
- Sector
- TOPS Consumer Discretionary
- NXL Health Care
- Exchange
- TOPS Nasdaq
- NXL Nasdaq
- Market Cap
- TOPS 26.6M
- NXL 31.1M
- IPO Year
- TOPS 2004
- NXL 2022
- Fundamental
- Price
- TOPS $5.97
- NXL $1.83
- Analyst Decision
- TOPS
- NXL Strong Buy
- Analyst Count
- TOPS 0
- NXL 1
- Target Price
- TOPS N/A
- NXL $5.00
- AVG Volume (30 Days)
- TOPS 9.5K
- NXL 106.1K
- Earning Date
- TOPS 05-06-2025
- NXL 05-09-2025
- Dividend Yield
- TOPS N/A
- NXL N/A
- EPS Growth
- TOPS N/A
- NXL N/A
- EPS
- TOPS 1.09
- NXL N/A
- Revenue
- TOPS $86,127,000.00
- NXL $168,721.00
- Revenue This Year
- TOPS $9.90
- NXL $79.59
- Revenue Next Year
- TOPS N/A
- NXL $334.65
- P/E Ratio
- TOPS $5.46
- NXL N/A
- Revenue Growth
- TOPS 3.83
- NXL 52.35
- 52 Week Low
- TOPS $5.30
- NXL $0.53
- 52 Week High
- TOPS $14.24
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- TOPS 51.33
- NXL 45.35
- Support Level
- TOPS $5.60
- NXL $1.71
- Resistance Level
- TOPS $5.85
- NXL $1.89
- Average True Range (ATR)
- TOPS 0.23
- NXL 0.20
- MACD
- TOPS 0.02
- NXL 0.04
- Stochastic Oscillator
- TOPS 95.30
- NXL 41.46
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The company focuses on the transportation of petroleum products (clean and dirty) and bulk liquid chemicals. The Company is an international provider of worldwide oil, petroleum products and chemical transportation services. It generates revenue from the Time Charter agreements.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.